122 related articles for article (PubMed ID: 286110)
1. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
[No Abstract] [Full Text] [Related]
2. Purification of soluble human melanoma-associated antigens.
Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
[TBL] [Abstract][Full Text] [Related]
3. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
4. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Burdick JF; Wells SA; Herberman RB
Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
[TBL] [Abstract][Full Text] [Related]
5. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
Weese JL; Herberman RB; Hollinshead AC; Cannon GB; Keels M; Kibrite A; Morales A; Char DH; Oldham RK
J Natl Cancer Inst; 1978 Feb; 60(2):255-63. PubMed ID: 74413
[No Abstract] [Full Text] [Related]
6. [Delayed hypersensitivity reaction in malignant melanoma].
Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
[No Abstract] [Full Text] [Related]
7. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
8. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma.
Char DH; Hollinshead A; Cogan DG; Ballintine EJ; Hogan MJ; Herberman RB
N Engl J Med; 1974 Aug; 291(6):274-7. PubMed ID: 4407111
[No Abstract] [Full Text] [Related]
9. [Cutaneous, cellular immunity in malignant melanoma].
Kehrer HC
Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
[No Abstract] [Full Text] [Related]
10. Delayed hypersensitivity reactions in patients with breast cancer.
Boeva M; Donchev T; Markova R; Christov I
Neoplasma; 1978; 25(6):733-6. PubMed ID: 752118
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
12. PHA and PPD skin responses in cancer patients.
Sinha R; Abassi KA; Gupta SC; Naithani YP
Indian J Cancer; 1983; 20(5):227-31. PubMed ID: 6680390
[No Abstract] [Full Text] [Related]
13. [State of the stroma in melanoma in patients with different delayed hypersensitivity reaction to neoplasm antigen].
Lavnikova GA; Voronina EA; Babakova SV
Vopr Onkol; 1978; 24(11):24-30. PubMed ID: 741696
[TBL] [Abstract][Full Text] [Related]
14. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
[No Abstract] [Full Text] [Related]
15. Human breast cancer. A model for cancer immunology.
Black MM
Isr J Med Sci; 1973 Mar; 9(3):284-99. PubMed ID: 4575653
[No Abstract] [Full Text] [Related]
16. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
17. Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.
Alford C; Hollinshead AC; Heberman RB
Ann Surg; 1973 Jul; 178(1):20-4. PubMed ID: 4717706
[No Abstract] [Full Text] [Related]
18. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
Rapaport FT; Lawrence HS
Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
[No Abstract] [Full Text] [Related]
19. Delayed cutaneous hypersensitivity reactions to tumor extracts in patients with cervical carcinoma.
Melewicz FC; Wells SA; Christiansen C; Ketcham A
Surg Forum; 1972; 23(0):94-6. PubMed ID: 4671036
[No Abstract] [Full Text] [Related]
20. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
